Patents by Inventor Manon WEIS

Manon WEIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240417440
    Abstract: The present invention relates to an isolated T cell receptor (TCR) specific for NY-ESO-1/LAGE-1 and a polypeptide comprising a functional portion of the TCR. Further implicated are a multivalent TCR complex, a nucleic acid encoding a TCR, a cell expressing the TCR and a pharmaceutical composition comprising the TCR. The invention also refers to the TCR for use as a medicament, in particular to the TCR for use in the treatment of cancer.
    Type: Application
    Filed: August 28, 2024
    Publication date: December 19, 2024
    Inventors: Carina WEHNER, Manon WEIS
  • Publication number: 20240083967
    Abstract: The present invention relates to the field of biotechnology. Specifically, the invention provides antigen-specific T-cell receptors (TCRs). Further, the invention encompasses polynucleotides encoding the same and vectors comprising said polynucleotides. Host cells comprising the molecules of the invention are also provided. Moreover, the invention provides means and methods for diagnostics and therapy, in particular of cancer.
    Type: Application
    Filed: August 21, 2023
    Publication date: March 14, 2024
    Applicant: MEDIGENE IMMUNOTHERAPIES GMBH
    Inventors: Christian ELLINGER, Carina WEHNER, Manon WEIS, Susanne WILDE, Dolores SCHENDEL
  • Publication number: 20220332784
    Abstract: The present invention relates to an isolated T cell receptor (TCR) specific for NY-ESO-1/LAGE-1 and a polypeptide comprising a functional portion of the TCR. Further implicated are a multivalent TCR complex, a nucleic acid encoding a TCR, a cell expressing the TCR and a pharmaceutical composition comprising the TCR. The invention also refers to the TCR for use as a medicament, in particular to the TCR for use in the treatment of cancer.
    Type: Application
    Filed: January 31, 2022
    Publication date: October 20, 2022
    Inventors: Carina WEHNER, Manon WEIS
  • Publication number: 20200148738
    Abstract: The present invention relates to an isolated T cell receptor (TCR) specific for NY-ESO-1/LAGE-1 and a polypeptide comprising a functional portion of the TCR. Further implicated are a multivalent TCR complex, a nucleic acid encoding a TCR, a cell expressing the TCR and a pharmaceutical composition comprising the TCR. The invention also refers to the TCR for use as a medicament, in particular to the TCR for use in the treatment of cancer.
    Type: Application
    Filed: January 28, 2019
    Publication date: May 14, 2020
    Applicant: MEDIGENE IMMUNOTHERAPIES GMBH
    Inventors: Carina WEHNER, Manon WEIS
  • Publication number: 20190169261
    Abstract: The present invention relates to the field of biotechnology. Specifically, the invention provides antigen-specific T-cell receptors (TCRs). Further, the invention encompasses polynucleotides encoding the same and vectors comprising said polynucleotides. Host cells comprising the molecules of the invention are also provided. Moreover, the invention provides means and methods for diagnostics and therapy, in particular of cancer.
    Type: Application
    Filed: June 16, 2017
    Publication date: June 6, 2019
    Applicant: MEDIGENE IMMUNOTHERAPIES GMBH
    Inventors: Christian ELLINGER, Carina WEHNER, Manon WEIS, Susanne WILDE, Dolores SCHENDEL